Insiders Updates
A company insider recently sold 4,740 shares of MoonLake Immunotherapeutics [MLTX]. Should You Sale?
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
MoonLake Immunotherapeutics’s recent filing unveils that its Chief Executive Officer Santos da Silva Jorge unloaded Company’s shares for reported $0.26
In a filing, MoonLake Immunotherapeutics revealed its Chief Executive Officer Santos da Silva Jorge unloaded Company’s shares for reported $0.26
MoonLake Immunotherapeutics’s filing revealed that its Chief Executive Officer Santos da Silva Jorge unloaded Company’s shares for reported $0.26 million
MoonLake Immunotherapeutics (NASDAQ:MLTX) does about 97.50K shares in volume on a normal day but saw 297168 shares change hands in